Editing Fibrosis (TRPM7)

{{tp|p=23934071|t=2013. Inhibition of TRPM7 channels prevents proliferation and differentiation of human lung fibroblasts.|pdf=|usr=}}{{23934071}}
{{tp|p=18268139|t=2008. Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium.|pdf=|usr=}}{{18268139}}
{{tp|p=29500887|t=2018. TGFbeta-induced epithelial-to-mesenchymal transition in prostate cancer cells is mediated via TRPM7 expression.|pdf=|usr=}}{{29500887}}
{{tp|p=25204892|t=2015. Novel insights into TRPM7 function in fibrotic diseases: a potential therapeutic target.|pdf=|usr=}}{{25204892}}
{{tp|p=25150141|t=2014. TGF-beta1-elevated TRPM7 channel regulates collagen expression in hepatic stellate cells via TGF-beta1/Smad pathway.|pdf=|usr=}}{{25150141}}
{{tp|p=24680379|t=2014. TRPM7 is involved in angiotensin II induced cardiac fibrosis development by mediating calcium and magnesium influx.|pdf=|usr=}}{{24680379}}
{{tp|p=37072467|t=2023. CBGA ameliorates inflammation and fibrosis in nephropathy.|pdf=|usr=}}{{37072467}}
{{tp|p=36384264|t=2022. TRPM7 Elicits Proliferation and Differentiation of Human Lens Epithelial Cells through the TGF-beta/Smad Pathways.|pdf=|usr=}}{{36384264}}
{{tp|p=35883700|t=2022. TRPM7 Modulates Human Pancreatic Stellate Cell Activation.|pdf=|usr=}}{{35883700}}
{{tp|p=35864199|t=2022. TRPM7 restrains plasmin activity and promotes transforming growth factor-beta1 signaling in primary human lung fibroblasts.|pdf=|usr=}}{{35864199}}
{{tp|p=33922466|t=2021. Channelling the Force to Reprogram the Matrix: Mechanosensitive Ion Channels in Cardiac Fibroblasts.|pdf=|usr=}}{{33922466}}
{{tp|p=33456540|t=2021. Role of TRPM7 in cardiac fibrosis: A potential therapeutic target (Review).|pdf=|usr=}}{{33456540}}
{{tp|p=33284571|t=2020. MiR-149 attenuates the proliferation and migration of TGF-beta1-induced airway smooth muscle cells by targeting TRPM7 and affecting downstream MAPK signal pathway.|pdf=|usr=}}{{33284571}}
{{tp|p=35850880|t=2023. Overexpression of TRPM7 promotes the therapeutic effect of curcumin in wound healing through the STAT3/SMAD3 signaling pathway in human fibroblasts.|pdf=|usr=}}{{35850880}}
{{tp|p=33647257|t=2021. Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway.|pdf=|usr=}}{{33647257}}
{{tp|p=33494094|t=2021. Transient Receptor Potential Melastatin 7 Promotes Vascular Adventitial Fibroblasts Phenotypic Transformation and Inflammatory Reaction Induced by Mechanical Stretching Stress via p38 MAPK/JNK Pathway.|pdf=|usr=}}{{33494094}}
{{tp|p=33143990|t=2021. Panax Notoginseng Saponins suppresses TRPM7 via the PI3K/AKT pathway to inhibit hypertrophic scar formation in vitro.|pdf=|usr=}}{{33143990}}
{{tp|p=31739105|t=2020. Astragaloside IV inhibits cardiac fibrosis via miR-135a-TRPM7-TGF-beta/Smads pathway.|pdf=|usr=}}{{31739105}}
{{tp|p=31640089|t=2019. TRPM7 deficiency suppresses cell proliferation, migration, and invasion in human colorectal cancer via regulation of epithelial-mesenchymal transition.|pdf=|usr=}}{{31640089}}
{{tp|p=30445149|t=2019. TRP channels in cardiac and intestinal fibrosis.|pdf=|usr=}}{{30445149}}
{{tp|p=30290314|t=2018. TGF-beta1-Induced Airway Smooth Muscle Cell Proliferation Involves TRPM7-Dependent Calcium Influx via TGFbetaR/SMAD3.|pdf=|usr=}}{{30290314}}
{{tp|p=29775892|t=2018. MicroRNA-135a inhibits cardiac fibrosis induced by isoproterenol via TRPM7 channel.|pdf=|usr=}}{{29775892}}
{{tp|p=29079194|t=2017. Role of ROS-TRPM7-ERK1/2 axis in high concentration glucose-mediated proliferation and phenotype switching of rat aortic vascular smooth muscle cells.|pdf=|usr=}}{{29079194}}
{{tp|p=28573641|t=2017. Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial-mesenchymal transition in prostate cancer cells.|pdf=|usr=}}{{28573641}}
{{tp|p=28393175|t=2017. TRPM7 channels mediate the functional changes in cardiac fibroblasts induced by angiotensin II.|pdf=|usr=}}{{28393175}}
{{tp|p=32706027|t=2020. Epidermal growth factor signaling through transient receptor potential melastatin 7 cation channel regulates vascular smooth muscle cell function.|pdf=|usr=}}{{32706027}}
{{tp|p=32047249|t=2020. TRPM7 contributes to progressive nephropathy.|pdf=|usr=}}{{32047249}}
{{tp|p=30819230|t=2019. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.|pdf=|usr=}}{{30819230}}
{{tp|p=29684587|t=2018. TRPM7 controls mesenchymal features of breast cancer cells by tensional regulation of SOX4.|pdf=|usr=}}{{29684587}}
{{tp|p=29511803|t=2018. TRPM7 regulates angiotensin II-induced sinoatrial node fibrosis in sick sinus syndrome rats by mediating Smad signaling.|pdf=|usr=}}{{29511803}}
{{tp|p=26164719|t=2015. Inhibition of TRPM7 Attenuates Rat Aortic Smooth Muscle Cell Proliferation Induced by Angiotensin II: Role of Genistein.|pdf=|usr=}}{{26164719}}
{{tp|p=25863514|t=2015. Effects of laser irradiation at different wavelengths (660, 810, 980, and 1064 nm) on transient receptor potential melastatin channels in an animal model of wound healing.|pdf=|usr=}}{{25863514}}
{{tp|p=27108806|t=2016. Upregulation of TRPM7 augments cell proliferation and interleukin-8 release in airway smooth muscle cells of rats exposed to cigarette smoke.|pdf=|usr=}}{{27108806}}
{{tp|p=26900082|t=2016. TRPM7 channel regulates ox-LDL-induced proliferation and migration of vascular smooth muscle cells via MEK-ERK pathways.|pdf=|usr=}}{{26900082}}
{{tp|p=24220678|t=2014. Blockage of TRPM7 channel induces hepatic stellate cell death through endoplasmic reticulum stress-mediated apoptosis.|pdf=|usr=}}{{24220678}}
{{tp|p=23958495|t=2013. TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways.|pdf=|usr=}}{{23958495}}
{{tp|p=24871786|t=2014. Transient receptor potential melastatin 7 (TRPM7) contributes to H2O2-induced cardiac fibrosis via mediating Ca(2+) influx and extracellular signal-regulated kinase 1/2 (ERK1/2) activation in cardiac fibroblasts.|pdf=|usr=}}{{24871786}}
{{tp|p=24710004|t=2014. Endotoxin induces fibrosis in vascular endothelial cells through a mechanism dependent on transient receptor protein melastatin 7 activity.|pdf=|usr=}}{{24710004}}
{{tp|p=24586847|t=2014. Magnesium inhibits Wnt/beta-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells.|pdf=|usr=}}{{24586847}}
{{tp|p=23686305|t=2014. Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent.|pdf=|usr=}}{{23686305}}
{{tp|p=23511028|t=2013. A TRP to cardiac fibroblast differentiation.|pdf=|usr=}}{{23511028}}
{{tp|p=23432060|t=2013. Transient receptor potential (TRP) channels and cardiac fibrosis.|pdf=|usr=}}{{23432060}}
{{tp|p=20075334|t=2010. TRPM7-mediated Ca2+ signals confer fibrogenesis in human atrial fibrillation.|pdf=|usr=}}{{20075334}}
{{tp|p=36747205|t=2023. Empagliflozin suppressed cardiac fibrogenesis through sodium-hydrogen exchanger inhibition and modulation of the calcium homeostasis.|pdf=|usr=}}{{36747205}}
{{tp|p=34331987|t=2021. Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.|pdf=|usr=}}{{34331987}}
{{tp|p=28506744|t=2017. Hepatic stellate cells as key target in liver fibrosis.|pdf=|usr=}}{{28506744}}
{{tp|p=37138582|t=2023. Integrating Network Pharmacology and Experimental Validation to Explore the Pharmacological Mechanism of Astragaloside IV in Treating Bleomycin-Induced Pulmonary Fibrosis.|pdf=|usr=}}{{37138582}}
{{tp|p=36408254|t=2022. Astragalus and its formulas as a therapeutic option for fibrotic diseases: Pharmacology and mechanisms.|pdf=|usr=}}{{36408254}}
{{tp|p=36160396|t=2022. Astragalus Mongholicus: A review of its anti-fibrosis properties.|pdf=|usr=}}{{36160396}}
{{tp|p=35656031|t=2022. Astragaloside IV Ameliorates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Fecal Metabolites.|pdf=|usr=}}{{35656031}}
{{tp|p=34811833|t=2022. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1alpha/SLC7A11 pathway.|pdf=|usr=}}{{34811833}}
{{tp|p=34594406|t=2021. Se alleviates homocysteine-induced fibrosis in cardiac fibroblasts via downregulation of lncRNA MEG3.|pdf=|usr=}}{{34594406}}
{{tp|p=36277193|t=2022. Ion channels as a therapeutic target for renal fibrosis.|pdf=|usr=}}{{36277193}}
{{tp|p=33082445|t=2020. Interleukin-11 is important for vascular smooth muscle phenotypic switching and aortic inflammation, fibrosis and remodeling in mouse models.|pdf=|usr=}}{{33082445}}
{{tp|p=37705977|t=2023. Multimodal roles of transient receptor potential channel activation in inducing pathological tissue scarification.|pdf=|usr=}}{{37705977}}
{{tp|p=31250885|t=2020. Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis.|pdf=|usr=}}{{31250885}}
{{tp|p=22406504|t=2012. Inhibition of transient receptor potential melastain 7 channel increases HSCs apoptosis induced by TRAIL.|pdf=|usr=}}{{22406504}}
{{tp|p=35837047|t=2022. MicroRNA-146a attenuates isoproterenol-induced cardiac fibrosis by inhibiting FGF2.|pdf=|usr=}}{{35837047}}
{{tp|p=35047019|t=2021. Single-Cell and Bulk Transcriptome Data Integration Reveals Dysfunctional Cell Types and Aberrantly Expressed Genes in Hypertrophic Scar.|pdf=|usr=}}{{35047019}}
{{tp|p=33569393|t=2020. Pivotal Role of TGF-beta/Smad Signaling in Cardiac Fibrosis: Non-coding RNAs as Effectual Players.|pdf=|usr=}}{{33569393}}
{{tp|p=32994970|t=2020. Malvidin induces hepatic stellate cell apoptosis via the endoplasmic reticulum stress pathway and mitochondrial pathway.|pdf=|usr=}}{{32994970}}
{{tp|p=32341639|t=2020. Isoliquiritigenin Attenuates UUO-Induced Renal Inflammation and Fibrosis by Inhibiting Mincle/Syk/NF-Kappa B Signaling Pathway.|pdf=|usr=}}{{32341639}}
{{tp|p=32104267|t=2020. miR-26b inhibits isoproterenol-induced cardiac fibrosis via the Keap1/Nrf2 signaling pathway.|pdf=|usr=}}{{32104267}}
{{tp|p=31555353|t=2019. Plantamajoside exerts antifibrosis effects in the liver by inhibiting hepatic stellate cell activation.|pdf=|usr=}}{{31555353}}
{{tp|p=31007736|t=2019. let-7a suppresses liver fibrosis via TGFbeta/SMAD signaling transduction pathway.|pdf=|usr=}}{{31007736}}
{{tp|p=29057165|t=2017. Mechanisms of Fibroblast Activation in the Remodeling Myocardium.|pdf=|usr=}}{{29057165}}
{{tp|p=28565783|t=2017. Traditional Chinese medicine baoxin decoction improves cardiac fibrosis of rats with dilated cardiomyopathy.|pdf=|usr=}}{{28565783}}
{{tp|p=27332862|t=2016. New Developments on the Treatment of Liver Fibrosis.|pdf=|usr=}}{{27332862}}
{{tp|p=23782569|t=2013. Cellular re- and de-programming by microenvironmental memory: why short TGF-beta1 pulses can have long effects.|pdf=|usr=}}{{23782569}}
{{tp|p=23448358|t=2013. Function and fate of myofibroblasts after myocardial infarction.|pdf=|usr=}}{{23448358}}
{{tp|p=14976548|t=2004. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition.|pdf=|usr=}}{{14976548}}
{{tp|p=37771726|t=2023. Drugs for treating myocardial fibrosis.|pdf=|usr=}}{{37771726}}
{{tp|p=36969589|t=2023. Progress on role of ion channels of cardiac fibroblasts in fibrosis.|pdf=|usr=}}{{36969589}}
{{tp|p=36843918|t=2023. Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: Focus on the TGF-beta/Smad signaling pathway.|pdf=|usr=}}{{36843918}}
{{tp|p=36299876|t=2022. Traditional Chinese medicine for hypertrophic scars-A review of the therapeutic methods and potential effects.|pdf=|usr=}}{{36299876}}
{{tp|p=36277180|t=2022. Emerging role of transient receptor potential (TRP) ion channels in cardiac fibroblast pathophysiology.|pdf=|usr=}}{{36277180}}
{{tp|p=35754495|t=2022. Research Progress of Traditional Chinese Medicine in Treatment of Myocardial fibrosis.|pdf=|usr=}}{{35754495}}
{{tp|p=35615675|t=2022. Mechanical Stretch Triggers Epithelial-Mesenchymal Transition in Keratinocytes Through Piezo1 Channel.|pdf=|usr=}}{{35615675}}
{{tp|p=35359592|t=2022. Focusing on Mechanoregulation Axis in Fibrosis: Sensing, Transduction and Effecting.|pdf=|usr=}}{{35359592}}
{{tp|p=34483934|t=2021. Huangqi Shengmai Yin Ameliorates Myocardial Fibrosis by Activating Sirtuin3 and Inhibiting TGF-beta/Smad Pathway.|pdf=|usr=}}{{34483934}}
{{tp|p=34055617|t=2021. Calcium Channel Protein ORAI1 Mediates TGF-beta Induced Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cells.|pdf=|usr=}}{{34055617}}
{{tp|p=33937049|t=2021. Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors.|pdf=|usr=}}{{33937049}}
{{tp|p=31849690|t=2019. PM(2.5), Fine Particulate Matter: A Novel Player in the Epithelial-Mesenchymal Transition?|pdf=|usr=}}{{31849690}}
{{tp|p=30250825|t=2018. Transforming Growth Factor-beta-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis.|pdf=|usr=}}{{30250825}}
{{tp|p=36950111|t=2023. Matrix stiffness induces epithelial-to-mesenchymal transition via Piezo1-regulated calcium flux in prostate cancer cells.|pdf=|usr=}}{{36950111}}
{{tp|p=35897650|t=2022. Piezo1 Channel as a Potential Target for Hindering Cardiac Fibrotic Remodeling.|pdf=|usr=}}{{35897650}}
{{tp|p=34984022|t=2021. Identification of ceRNA (lncRNA-miRNA-mRNA) Regulatory Network in Myocardial Fibrosis After Acute Myocardial Infarction.|pdf=|usr=}}{{34984022}}
{{tp|p=34927020|t=2021. Liver sphingomyelin synthase 1 deficiency causes steatosis, steatohepatitis, fibrosis, and tumorigenesis: An effect of glucosylceramide accumulation.|pdf=|usr=}}{{34927020}}
{{ttp|p=34360952|t=2021. Transient Receptor Potential Channels in the Epithelial-to-Mesenchymal Transition.|pdf=|usr=}}{{34360952}}
{{tp|p=32705273|t=2020. Inhibition of miRNAâ€‘135aâ€‘5p ameliorates TGFâ€‘beta1â€‘induced human renal fibrosis by targeting SIRT1 in diabetic nephropathy.|pdf=|usr=}}{{32705273}}
{{tp|p=29115395|t=2018. Transforming growth factor beta1 promotes migration and invasion in HepG2 cells: Epithelialâ€‘toâ€‘mesenchymal transition via JAK/STAT3 signaling.|pdf=|usr=}}{{29115395}}
{{tp|p=26909046|t=2016. Promising Therapy Candidates for Liver Fibrosis.|pdf=|usr=}}{{26909046}}
{{tp|p=35671705|t=2023. Mannan-Binding Lectin Reduces Epithelial-Mesenchymal Transition in Pulmonary Fibrosis via Inactivating the Store-Operated Calcium Entry Machinery.|pdf=|usr=}}{{35671705}}
{{tp|p=33028359|t=2020. Calreticulin promotes EMT in pancreatic cancer via mediating Ca(2+) dependent acute and chronic endoplasmic reticulum stress.|pdf=|usr=}}{{33028359}}
{{tp|p=32047557|t=2020. Molecular Mechanism of Pancreatic Stellate Cells Activation in Chronic Pancreatitis and Pancreatic Cancer.|pdf=|usr=}}{{32047557}}
{{tp|p=31547577|t=2019. Ca(2+) Signaling in Cardiac Fibroblasts and Fibrosis-Associated Heart Diseases.|pdf=|usr=}}{{31547577}}
{{tp|p=30577808|t=2018. SIRT6 drives epithelial-to-mesenchymal transition and metastasis in non-small cell lung cancer via snail-dependent transrepression of KLF4.|pdf=|usr=}}{{30577808}}
{{tp|p=30563389|t=2019. K(Ca)3.1 Channels Promote Cardiac Fibrosis Through Mediating Inflammation and Differentiation of Monocytes Into Myofibroblasts in Angiotensin II -Treated Rats.|pdf=|usr=}}{{30563389}}
{{tp|p=28922779|t=2018. Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4.|pdf=|usr=}}{{28922779}}
{{tp|p=28550085|t=2017. Knockdown of sodium-calcium exchanger 1 induces epithelial-to-mesenchymal transition in kidney epithelial cells.|pdf=|usr=}}{{28550085}}
{{tp|p=28332284|t=2017. EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis.|pdf=|usr=}}{{28332284}}
{{tp|p=27167848|t=2016. Molecular networks underlying myofibroblast fate and fibrosis.|pdf=|usr=}}{{27167848}}
{{tp|p=24189039|t=2014. Myofibroblasts: trust your heart and let fate decide.|pdf=|usr=}}{{24189039}}
{{tp|p=32895361|t=2020. Lower Metal Element Levels in Hypertrophic Scars: A Potential Mechanism of Aberrant Cicatrix Hyperplasia.|pdf=|usr=}}{{32895361}}
{{tp|p=32416242|t=2020. Regulators of cardiac fibroblast cell state.|pdf=|usr=}}{{32416242}}
{{tp|p=32358524|t=2020. Context specificity of the EMT transcriptional response.|pdf=|usr=}}{{32358524}}
{{tp|p=29119737|t=2017. Endostatin inhibits fibrosis by modulating the PDGFR/ERK signal pathway: an in vitro study.|pdf=|usr=}}{{29119737}}
{{tp|p=28099257|t=2017. Antifibrotic Effect of Saturated Fatty Acids via Endoplasmic Reticulum Stress Response in Rat Pancreatic Stellate Cells.|pdf=|usr=}}{{28099257}}
{{tp|p=22370643|t=2013. MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms.|pdf=|usr=}}{{22370643}}
{{tp|p=20501797|t=2010. Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis.|pdf=|usr=}}{{20501797}}
{{tp|p=35836819|t=2022. Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation.|pdf=|usr=}}{{35836819}}
{{tp|p=34158869|t=2021. Elevated IgE promotes cardiac fibrosis by suppressing miR-486a-5p.|pdf=|usr=}}{{34158869}}
{{tp|p=33500351|t=2021. GRK5 is a regulator of fibroblast activation and cardiac fibrosis.|pdf=|usr=}}{{33500351}}
{{tp|p=35117228|t=2020. MEST promotes bladder cancer cell proliferation, migration and invasion via STAT3/Twist-1-mediated EMT.|pdf=|usr=}}{{35117228}}
{{tp|p=32632340|t=2020. Prostate Cancer Epithelial Mesenchymal Transition by TGF-beta1 exposure monitored with a Photonic Crystal Biosensor.|pdf=|usr=}}{{32632340}}
{{tp|p=31719171|t=2019. Translocation of TRPV4-PI3Kgamma complexes to the plasma membrane drives myofibroblast transdifferentiation.|pdf=|usr=}}{{31719171}}
{{tp|p=31476281|t=2019. siRNA- and miRNA-based therapeutics for liver fibrosis.|pdf=|usr=}}{{31476281}}
{{tp|p=28507335|t=2017. BNIP3L promotes cardiac fibrosis in cardiac fibroblasts through [Ca(2+)](i)-TGF-beta-Smad2/3 pathway.|pdf=|usr=}}{{28507335}}
{{tp|p=28546859|t=2016. STAT3 Inhibition Suppresses Hepatic Stellate Cell Fibrogenesis: HJC0123, a Potential Therapeutic Agent for Liver Fibrosis.|pdf=|usr=}}{{28546859}}
{{tp|p=30254408|t=2018. Daikenchuto (Da-Jian-Zhong-Tang) ameliorates intestinal fibrosis by activating myofibroblast transient receptor potential ankyrin 1 channel.|pdf=|usr=}}{{30254408}}
{{tp|p=26109801|t=2015. Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats.|pdf=|usr=}}{{26109801}}
{{tp|p=36970190|t=2023. S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung.|pdf=|usr=}}{{36970190}}
{{tp|p=35884879|t=2022. Klotho Modulates Pro-Fibrotic Activities in Human Atrial Fibroblasts through Inhibition of Phospholipase C Signaling and Suppression of Store-Operated Calcium Entry.|pdf=|usr=}}{{35884879}}
{{tp|p=35517894|t=2022. Curcumin Prevents Epithelial-to Mesenchymal Transition-Mediated Ovarian Cancer Progression through NRF2/ETBR/ET-1 Axis and Preserves Mitochondria Biogenesis in Kidney after Cisplatin Administration.|pdf=|usr=}}{{35517894}}
{{tp|p=35148253|t=2022. ASK1 Regulates Bleomycin-induced Pulmonary Fibrosis.|pdf=|usr=}}{{35148253}}
{{tp|p=33014530|t=2020. Roles of Biomarkers in Myocardial Fibrosis.|pdf=|usr=}}{{33014530}}
{{tp|p=31486669|t=2020. The Role of KCNMB1 and BK Channels in Myofibroblast Differentiation and Pulmonary Fibrosis.|pdf=|usr=}}{{31486669}}
{{tp|p=27398165|t=2016. Anticytoproliferative effect of Vitamin C on rat hepatic stellate cell.|pdf=|usr=}}{{27398165}}
{{tp|p=26047667|t=2016. Experimental models of liver fibrosis.|pdf=|usr=}}{{26047667}}
{{tp|p=35136027|t=2022. ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-beta/Smad signaling pathway.|pdf=|usr=}}{{35136027}}
{{tp|p=34831281|t=2021. TRPV4 Mechanotransduction in Fibrosis.|pdf=|usr=}}{{34831281}}
{{tp|p=34359993|t=2021. Fibrosis, the Bad Actor in Cardiorenal Syndromes: Mechanisms Involved.|pdf=|usr=}}{{34359993}}
{{ttp|p=32673537|t=2020. Myofibroblasts and Fibrosis: Mitochondrial and Metabolic Control of Cellular Differentiation.|pdf=|usr=}}{{32673537}}
{{tp|p=32329036|t=2020. Transient receptor potential channel TRPV4 mediates TGF-beta1-induced differentiation of human ventricular fibroblasts.|pdf=|usr=}}{{32329036}}
{{tp|p=32085494|t=2020. Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis Development.|pdf=|usr=}}{{32085494}}
{{tp|p=32065054|t=2020. T-Cell-Derived miRNA-214 Mediates Perivascular Fibrosis in Hypertension.|pdf=|usr=}}{{32065054}}
{{tp|p=31758702|t=2020. Ca(2+) signalling in fibroblasts and the therapeutic potential of K(Ca)3.1 channel blockers in fibrotic diseases.|pdf=|usr=}}{{31758702}}
{{tp|p=30796204|t=2019. circHIPK3 regulates lung fibroblast-to-myofibroblast transition by functioning as a competing endogenous RNA.|pdf=|usr=}}{{30796204}}
{{tp|p=29552620|t=2018. Activation of Myofibroblast TRPA1 by Steroids and Pirfenidone Ameliorates Fibrosis in Experimental Crohn's Disease.|pdf=|usr=}}{{29552620}}
{{tp|p=36674805|t=2023. Calcium-Signalling in Human Glaucoma Lamina Cribrosa Myofibroblasts.|pdf=|usr=}}{{36674805}}
{{tp|p=24935972|t=2014. Endotoxin-induced endothelial fibrosis is dependent on expression of transforming growth factors beta1 and beta2.|pdf=|usr=}}{{24935972}}
{{ttp|p=23635013|t=2013. Lipopolysaccharide induces a fibrotic-like phenotype in endothelial cells.|pdf=|usr=}}{{23635013}}
{{tp|p=32730639|t=2021. Melatonin ameliorates PM(2.5) -induced cardiac perivascular fibrosis through regulating mitochondrial redox homeostasis.|pdf=|usr=}}{{32730639}}
{{ttp|p=30864875|t=2019. Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases.|pdf=|usr=}}{{30864875}}
{{tp|p=32606340|t=2020. Investigating the antifibrotic effect of the antiparasitic drug Praziquantel in in vitro and in vivo preclinical models.|pdf=|usr=}}{{32606340}}
{{tp|p=37431884|t=2023. Oridonin suppresses gastric cancer SGC-7901 cell proliferation by targeting the TNF-alpha/androgen receptor/TGF-beta signalling pathway axis.|pdf=|usr=}}{{37431884}}
{{tp|p=31383731|t=2019. The Extracellular Matrix Receptor Discoidin Domain Receptor 1 Regulates Collagen Transcription by Translocating to the Nucleus.|pdf=|usr=}}{{31383731}}